Haanen, J B A G <br/><br/>
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Apr 2006 
 - 451-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/s00262-005-0018-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Antibody Formation<br/>Antigens, Neoplasm<br/>BCG Vaccine--administration & dosage<br/>CD8-Positive T-Lymphocytes<br/>Cancer Vaccines--immunology<br/>Female<br/>Humans<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Neoplasm Staging<br/>Predictive Value of Tests<br/>Prognosis<br/>Skin Neoplasms--immunology<br/>Survival<br/>Treatment Outcome<br/>Tumor Cells, Cultured--immunology